Iovance Biotherapeutics, Inc.
Restimulation of cryopreserved tumor infiltrating lymphocytes

Abstract:

The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.